Dechra Pharmaceuticals PLC (LSE:DPH) - Share price - Overview

Stock Report

Dechra Pharmaceuticals PLC DPH

Last Price
GBX2,127.00

Day Change
2.00|0.09%

As of 20/11/2017
15:29:22 GMT | GBX
Minimum 15 Minutes Delay.

Last Close2,125.00p
Day Range2,118.00 - 2,142.00
Mkt Cap1.99Bil
52-Wk Range1,225.00 - 2,199.00
Yield %0.89
ISINGB0009633180
Volume39,547
P/E66.07
P/S5.50
P/CF25.53

Share Price

Total Returns 17/11/2017

 Chg (%)  
More ...
Dechra Pharmaceuticals PLC1.34 
FTSE 100 TR GBP-1.44
 
Financials
201520162017
More ...
Income Statement
Turnover203.48247.56359.28
Operating Profit25.9819.4933.21
Net Profit19.4612.5126.11
Reported EPS21.9914.0727.93
Balance Sheet
Current Assets108.62162.39184.98
Non Current Assets184.90393.44453.09
Total Assets293.53555.83638.07
Current Liabilities44.1165.9866.41
Total Liabilities99.04279.22335.43
Total Equity194.49276.61302.64
Cash Flow
Operating Cash Flow46.9956.4594.27
Net Change in Cash21.51-5.1521.74
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
201888.4773.03126.8529.100.2323.131.09
201999.2081.1911.1726.172.3425.161.18

Regulatory News

Director Dealings
TradedActionNotifierPriceAmountValue
More ...
19/09/2017Sale of Option SharesMr. Ian Page2,023.9254,9101,111,333.00
19/09/2017Sale of Option SharesMr. Tony Griffin2,023.9229,937605,900.00
15/09/2017Exercise of OptionMr. Ian Page0.00115,3340.00
15/09/2017Exercise of OptionMr. Tony Griffin0.0029,9370.00

Company Profile

Dechra Pharmaceuticals PLC is engaged in veterinary pharmaceuticals and related products business. The company is engaged in development, manufacture and marketing of products for veterinarians.

Sector

Drug Manufacturers - Major

Market Position

198 of 1833 Companies

Index

FTSE 250 ,FTSE 350 ,FTSE All Share

Outlook

(30/06/2017) "Current trading is in line with the board expectations and we anticipate delivering our strategic objectives in the new financial year"

Next Event 27/02/2018

Next interim announcement
Ratios
CompSecMkt
More ...
PER (E)27.9013.6316.14
Div Yld (E)1.134.134.26
PEG (E)0.471.241.34
ROCE22.76180.3415.81
Op Mrgn9.05-8.42-9.53
EPS Grwth59.1412.8214.73
Dividends
PreviousLatest
More ...
Record Date10/03/1727/10/17
Ex-Div09/03/1726/10/17
Paid07/04/1717/11/17
Amnt6.1115.33

Broker Sentiment

Strong Buy0
Buy3
Hold1
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr. Tony Rice
Chief ExecutiveMr. Ian Page
Chief Financial OfficerMr. Richard Cotton
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.